Position in ALEC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$86,425
+$6,061 QoQ
Shares Held
42,998
+15.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. ALEC ranks #278 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ALEC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,425 | 42,998 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $80,364 | 37,379 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $50,891 | 32,623 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $403,697 | 136,385 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $63,687 | 45,491 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,827,962 | 1,486,149 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,104,456 | 1,642,570 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,716,314 | 2,728,823 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $7,520,622 | 1,656,525 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $10,328,898 | 1,715,764 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $14,874,703 | 1,863,998 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $14,828,630 | 2,288,369 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,388,323 | 2,394,064 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $14,744,467 | 2,381,982 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $22,339,311 | 2,420,294 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $22,553,499 | 2,384,091 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,144,870 | 2,474,889 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $34,991,828 | 2,455,567 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $52,175,011 | 2,526,635 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $58,416,757 | 2,559,893 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $55,112,886 | 2,645,842 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $52,714,394 | 2,617,398 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $37,408,198 | 2,472,452 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $18,077,225 | 1,715,921 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $40,076,955 | 1,639,810 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $38,059,860 | 1,577,284 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||